Literature DB >> 27461854

Targeting cellular and microenvironmental multidrug resistance.

Okan Tezcan1, Tarun Ojha1,2, Gert Storm3,2, Fabian Kiessling1, Twan Lammers1,3,2.   

Abstract

Entities:  

Keywords:  Multi drug resistance; cancer; drug delivery; nanomedicine; tumor microenvironment

Year:  2016        PMID： 27461854      PMCID： PMC5404720          DOI： 10.1080/17425247.2016.1214570

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  15 in total

1.  Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Authors:  Forrest M Kievit; Freddy Y Wang; Chen Fang; Hyejung Mok; Kui Wang; John R Silber; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

2.  Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes.

Authors:  Niravkumar R Patel; Alok Rathi; Dmitriy Mongayt; Vladimir P Torchilin
Journal:  Int J Pharm       Date:  2011-06-15       Impact factor: 5.875

3.  Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.

Authors:  Sabine H van Rijt; Deniz A Bölükbas; Christian Argyo; Stefan Datz; Michael Lindner; Oliver Eickelberg; Melanie Königshoff; Thomas Bein; Silke Meiners
Journal:  ACS Nano       Date:  2015-03-02       Impact factor: 15.881

4.  Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation.

Authors:  Tracy T Batchelor; Elizabeth R Gerstner; Kyrre E Emblem; Dan G Duda; Jayashree Kalpathy-Cramer; Matija Snuderl; Marek Ancukiewicz; Pavlina Polaskova; Marco C Pinho; Dominique Jennings; Scott R Plotkin; Andrew S Chi; April F Eichler; Jorg Dietrich; Fred H Hochberg; Christine Lu-Emerson; A John Iafrate; S Percy Ivy; Bruce R Rosen; Jay S Loeffler; Patrick Y Wen; A Greg Sorensen; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

5.  Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer.

Authors:  Yanzuo Chen; Wei Zhang; Jijin Gu; Qiuyue Ren; Zhuoyang Fan; Weitong Zhong; Xiaoling Fang; Xianyi Sha
Journal:  Int J Pharm       Date:  2013-05-17       Impact factor: 5.875

6.  Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.

Authors:  Jin-Ming Yang; Zude Xu; Hao Wu; Hongguang Zhu; Xiaohua Wu; William N Hait
Journal:  Mol Cancer Res       Date:  2003-04       Impact factor: 5.852

Review 7.  Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.

Authors:  Dai Fukumura; Rakesh K Jain
Journal:  Microvasc Res       Date:  2007-05-18       Impact factor: 3.514

Review 8.  The tumor microenvironment is a dominant force in multidrug resistance.

Authors:  Ana Luísa Correia; Mina J Bissell
Journal:  Drug Resist Updat       Date:  2012-02-13       Impact factor: 18.500

Review 9.  Multidrug resistance: Physiological principles and nanomedical solutions.

Authors:  Sijumon Kunjachan; Błażej Rychlik; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

10.  MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.

Authors:  Xiaoqian Yang; Arun K Iyer; Amit Singh; Edwin Choy; Francis J Hornicek; Mansoor M Amiji; Zhenfeng Duan
Journal:  Sci Rep       Date:  2015-02-17       Impact factor: 4.379
View more
  4 in total

1.  Effects of extracellular acidity on resistance to chemotherapy treatment: a systematic review.

Authors:  Viviane Palmeira da Silva; Carulina Bueno Mesquita; Júlia Silveira Nunes; Bianca de Bem Prunes; Pantelis Varvaki Rados; Fernanda Visioli
Journal:  Med Oncol       Date:  2018-10-30       Impact factor: 3.064

2.  Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drugs.

Authors:  Elodie Jouberton; Aurélien Voissiere; Frédérique Penault-Llorca; Florent Cachin; Elisabeth Miot-Noirault
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 3.  Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer.

Authors:  Teodora Costea; Oana Cezara Vlad; Luminita-Claudia Miclea; Constanta Ganea; János Szöllősi; Maria-Magdalena Mocanu
Journal:  Int J Mol Sci       Date:  2020-01-08       Impact factor: 5.923

Review 4.  Application of Nano-Drug Delivery System Based on Cascade Technology in Cancer Treatment.

Authors:  Ying Sun; Xiaoli Ma; Hao Hu
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.